Subsys Spray Lawsuit
Subsys—the spray form of Fentanyl, a powerful synthetic opioid—has been linked to hundreds of cases of death and hospitalization of individuals. As a painkiller, Subsys is 100 times more potent than morphine and has therefore proven useful in providing pain relief to terminal cancer patients. However, it has shockingly been prescribed regularly for off-label use in non-terminal patients who have no signs of cancer. A drug is prescribed “off-label” when it is offered to a patient for a use that is not explicitly approved by the FDA.
The attorneys of Williams Kherkher have a lot of experience litigating pharmaceutical cases where there is a lot of nuance in whether a drug’s off-label prescription was justified or not. While the off-label use of drugs can often be risky, there are some drugs where these risks can be described as minimal. Subsys is not one of those drugs. Its power as an opioid, inherent risk of addiction, and potential to be fatal should each disqualify it from off-label use in effectively all cases. Nevertheless, it has been inappropriately used in non-cancer patients and led to numerous fatalities.
Fentanyl Oral Spray Lawsuit
It is no secret that pharmaceutical salespeople often market drugs specifically for off-label use, offering doctors kickbacks for meeting with them or prescribing their products to patients. While this practice is surprisingly commonplace, it is incredibly unethical. Doctors should not be motivated by the prospect of being rewarded for prescribing one drug over another, especially when a drug has serious inherent risks.
Reports have found that the drug’s manufacturer, Insys Therapeutics, has encouraged doctors to prescribe Subsys oral spray to patients who do not really need it. These prescriptions are issued despite the risk of death associated with the drug, which is directly written on its label. There have even been instances where the company helped patients who had no signs of cancer falsify cancer diagnoses in order to receive Subsys and thereby increase its sales.
Opioid drugs are notorious for being incredibly addictive. As people were prescribed a Subsys for migraines or other conditions that do not necessitate such a powerful drug, they often became addicted to it. With the cost of a single package of Subsys ranging from $300 to $9,000, there was a lot of incentive for Insys in increasing their product’s reach, however unethically. These illegal and irresponsible practices helped Subsys sales soar to over $90 million in the third quarter of 2015 alone, which comes at the cost of hundreds of overdose deaths, lost loved ones, and shattered lives that could reasonably be attributed to the drug.
Contact a Fentanyl Spray Lawsuit Attorney
Subsys oral sprays should never be prescribed to patients who do not have terminal cancer. If you have lost a loved one or have been hospitalized after being given Subsys oral spray for a non-cancerous condition, you may be able to hold the drug’s manufacturer accountable for your immeasurable loss. The attorneys of Williams Kherkher have a long history of helping people who have been used and abused by big-money corporations. Call (877) 614-0333 to speak with one of our experienced and compassionate attorneys today. We are poised and prepared to do everything in our power to stand up for your rights against pharmaceutical companies who put increasing their profits over public health.